Gw&K Investment Management, LLC Verona Pharma PLC Transaction History
Gw&K Investment Management, LLC
- $11.2 Billion
- Q2 2025
A detailed history of Gw&K Investment Management, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 193,782 shares of VRNA stock, worth $20.7 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
193,782
Previous 194,112
0.17%
Holding current value
$20.7 Million
Previous $12.3 Million
48.72%
% of portfolio
0.16%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding VRNA
# of Institutions
322Shares Held
76.8MCall Options Held
977KPut Options Held
3.12M-
Janus Henderson Group PLC London, X06.13MShares$655 Million0.3% of portfolio
-
Perceptive Advisors LLC New York, NY5.51MShares$588 Million22.87% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.13MShares$441 Million16.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$361 Million16.88% of portfolio
-
Rtw Investments, LP New York, NY3.05MShares$326 Million4.43% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.51B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...